{
  "actions": [
    {
      "acted_at": "2003-05-20", 
      "committee": "House Committee on Energy and Commerce", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Energy and Commerce.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2003-06-02", 
      "in_committee": "House Committee on Energy and Commerce", 
      "references": [], 
      "subcommittee": "Health", 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr2161-108", 
  "bill_type": "hr", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }
  ], 
  "congress": "108", 
  "cosponsors": [
    {
      "district": "1", 
      "name": "Allen, Thomas H.", 
      "sponsored_at": "2003-06-03", 
      "state": "ME", 
      "thomas_id": "01461", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "8", 
      "name": "Emerson, Jo Ann", 
      "sponsored_at": "2003-06-05", 
      "state": "MO", 
      "thomas_id": "01481", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "1", 
      "name": "Gutknecht, Gil", 
      "sponsored_at": "2003-05-22", 
      "state": "MN", 
      "thomas_id": "00479", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2003-05-20", 
  "number": "2161", 
  "official_title": "To require the Agency for Healthcare Research and Quality to collect and assess scientific evidence regarding prescription drugs frequently used by Medicare or Medicaid beneficiaries, and for other purposes.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Prescription Value Act", 
  "sponsor": {
    "district": "1", 
    "name": "Bereuter, Doug", 
    "state": "NE", 
    "thomas_id": "00080", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2003-05-20", 
  "subjects": [
    "Congress", 
    "Congressional reporting requirements", 
    "Cost effectiveness", 
    "Drug utilization", 
    "Drugs", 
    "Government operations and politics", 
    "Government paperwork", 
    "Governmental investigations", 
    "Health", 
    "Medicaid", 
    "Medicare", 
    "Pharmaceutical research", 
    "Science, technology, communications", 
    "Social welfare"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced", 
    "date": "2003-05-20", 
    "text": "Prescription Value Act - Directs the Director of the Agency for Healthcare Research and Quality to: (1) collect scientific evidence regarding the relative clinical appropriateness and cost-effectiveness of prescription drugs frequently used by Medicare and Medicaid beneficiaries; (2) assess the validity and reliability of such evidence; and (3) identify areas of additional research needed to make an objective determination on the clinical appropriateness and cost-effectiveness of such drugs."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Prescription Value Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To require the Agency for Healthcare Research and Quality to collect and assess scientific evidence regarding prescription drugs frequently used by Medicare or Medicaid beneficiaries, and for other purposes.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-07-14T19:01:24-04:00"
}